Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients.
about
Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trialThe clinical use of structural MRI in Alzheimer diseaseCalibrating longitudinal cognition in Alzheimer's disease across diverse test batteries and datasets.Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?Spatiotemporal linear mixed effects modeling for the mass-univariate analysis of longitudinal neuroimage data.Statistical analysis of longitudinal neuroimage data with Linear Mixed Effects models.Advances in longitudinal studies of amnestic mild cognitive impairment and Alzheimer's disease based on multi-modal MRI techniques.Using structural and diffusion magnetic resonance imaging to differentiate the dementias.The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial.Imaging in Alzheimer's disease.Association of blood pressure elevation and nocturnal dipping with brain atrophy, perfusion and functional measures in stroke and nonstroke individualsMRI Visual Ratings of Brain Atrophy and White Matter Hyperintensities across the Spectrum of Cognitive Decline Are Differently Affected by Age and DiagnosisHippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures.CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease.Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease.Human brain changes across the life span: a review of 56 longitudinal magnetic resonance imaging studies.Relationship between regional atrophy rates and cognitive decline in mild cognitive impairmentSex and age differences in atrophic rates: an ADNI study with n=1368 MRI scansLocalized hippocampus measures are associated with Alzheimer pathology and cognition independent of total hippocampal volumeCortical gyrification and sulcal spans in early stage Alzheimer's disease.Cerebral atrophy, apolipoprotein E varepsilon4, and rate of decline in everyday function among patients with amnestic mild cognitive impairmentSparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data.Effect of hypoglycemia on brain structure in people with type 2 diabetes: epidemiological analysis of the ACCORD-MIND MRI trial.Probabilistic MRI brain anatomical atlases based on 1,000 Chinese subjects.Longitudinal assessment of global and regional atrophy rates in Alzheimer's disease and dementia with Lewy bodies.Temporal evolution of biomarkers and cognitive markers in the asymptomatic, MCI, and dementia stage of Alzheimer's diseaseBiomarkers in Alzheimer's disease.Maximal brain size remains an important predictor of cognition in old age, independent of current brain pathology.Predictive Models Based on Support Vector Machines: Whole-Brain versus Regional Analysis of Structural MRI in the Alzheimer's DiseaseCerebrospinal fluid biomarkers and cerebral atrophy in distinct clinical variants of probable Alzheimer's disease.Clinical Significance of Fronto-Temporal Gray Matter Atrophy in Executive Dysfunction in Patients with Chronic Kidney Disease: The VCOHP Study.The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.The bidirectional association between reduced cerebral blood flow and brain atrophy in the general populationAtrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease.Effects of epsilon4 on object recognition in the non-demented elderly.Gray matter atrophy rate as a marker of disease progression in AD.Regional rates of neocortical atrophy from normal aging to early Alzheimer disease.Accelerating regional atrophy rates in the progression from normal aging to Alzheimer's disease.Folate and Vitamin B12-Related Biomarkers in Relation to Brain VolumesLower cerebral blood flow is associated with faster cognitive decline in Alzheimer's disease.
P2860
Q21136174-B54EE8AE-30BB-4B0A-8A64-284869EF5237Q24609648-EE69335E-84D0-4A9E-AA06-91C6B3E6004FQ27345159-F5085BA1-C1CC-4FAF-AADE-BD0AD439E43AQ28070156-6ED618F8-B1B7-4E74-A363-8ADDB3F91CA4Q30486156-271C6D39-273D-4C92-8E09-67D872C28AC8Q30576007-16233D66-BEA5-4DA0-9B83-5E40BB8A554FQ30765803-944EF12E-23A8-41C3-9ACE-F7F5B69441CBQ30836806-EB1C0ED0-43EC-446E-85C8-87212DEED465Q30874688-1F642BDB-0064-41A1-9E47-AD62DB4C223EQ33479675-AC065AF2-153B-4427-B507-06C4D38D1F93Q33607750-2C98FDBB-00EE-4FBC-B181-8B8F6F780C12Q33650376-5C3A0734-34C1-4898-85C1-F6F5C7D3F347Q33652639-E2082B48-6DD3-4985-A9ED-1E5FBA2C60F7Q33689474-1AAB2030-ADEF-4E10-BA41-A126CA854E5BQ33754677-165CEB23-D1C1-4891-B33B-A3E313A7BCC3Q34019300-B2679D0D-1221-4C66-B790-2C2E6F0A6D73Q34073224-A4CDC2B6-9094-4B09-BB74-637E457A0E20Q34081087-62CE876C-56BA-4B7B-9512-E4F6BE343A07Q34101122-7553EDBF-320C-4B44-92B0-1F3F97C69C6BQ34170510-0AF68B65-A4C0-42C3-94D1-2CAAE7379D3DQ34175825-4ADB0BC4-B582-49AA-93B8-4C9A76F03CA9Q34316574-1ECB0402-9A54-4CD4-9776-DE0B47669475Q34545326-6DFA5143-1A9E-44A4-9EFD-98F387067A26Q34558131-2093A61A-6C55-4E68-90D6-4C3B8361C87BQ35074859-B262C14F-EFEB-4350-8C25-B6E5B7FA22CCQ35106997-95E085BC-3698-482F-9B88-F4085C682329Q35113795-8532624B-7EAB-43C8-A8CC-C86163A4A160Q35226214-E8DEC6CF-F89C-4860-ADF3-0E5CF7C70F9BQ35305144-8AF0D39F-D845-4D17-BA9B-74A2B73F6953Q35735066-AFFF0DCD-F5C2-486C-A839-877D35959F97Q35859784-1AA9715A-DBDC-4641-82D4-BCDF54924ABBQ36217479-965BCD0B-F4B0-454B-BAE3-099DAD8898E1Q36254382-1F31E9A5-FE1C-4B4A-8E2F-6C92FE52AF8AQ36408912-D3BB4E14-204B-4E2E-A779-3D970275F6EFQ36847461-9CED362F-523B-44ED-BCA6-90B43E5ECB6DQ36852817-516A088B-06B6-4D0D-962F-89D06E633449Q37305759-4B99A54E-9CD2-4014-9F85-291C1C10BB03Q37424613-B7AA7F25-87B3-4C70-86AB-F952FC7F94F6Q37628312-250D87BD-146E-4106-8DAE-4D5FA066B9B6Q37639685-1B28A1B4-4155-4405-87CA-262A184CE895
P2860
Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Whole-brain atrophy rate and c ...... udy of memory clinic patients.
@en
Whole-brain atrophy rate and c ...... udy of memory clinic patients.
@nl
type
label
Whole-brain atrophy rate and c ...... udy of memory clinic patients.
@en
Whole-brain atrophy rate and c ...... udy of memory clinic patients.
@nl
prefLabel
Whole-brain atrophy rate and c ...... udy of memory clinic patients.
@en
Whole-brain atrophy rate and c ...... udy of memory clinic patients.
@nl
P2093
P50
P1433
P1476
Whole-brain atrophy rate and c ...... udy of memory clinic patients.
@en
P2093
Giorgos B Karas
Hugo Vrenken
Jasper D Sluimer
P304
P356
10.1148/RADIOL.2482070938
P407
P577
2008-06-23T00:00:00Z